Stifel Financial’s Filana Therapeutics FLNA Stock Holding History

Stifel Financial’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$177K	Buy	200,000 +125,000	+167%	+$118K	﹤0.01%	3569
2026 Q2	$89.2K	Buy	+75,000	New	+$107K	﹤0.01%	3625
2022 Q3	–	Sell	-87,175	Closed	-$2.45M	–	3372
2022 Q2	$2.45M	Sell	87,175 -2,872	-3%	-$72.5K	﹤0.01%	1370
2022 Q1	$3.34M	Buy	90,047 +1,402	+2%	+$59.4K	﹤0.01%	1278
2021 Q4	$3.87M	Buy	88,645 +33,978	+62%	+$1.78M	0.01%	1211
2021 Q3	$3.39M	Sell	54,667 -4,511	-8%	-$376K	0.01%	1241
2021 Q2	$5.06M	Buy	59,178 +4,300	+8%	+$230K	0.01%	1024
2021 Q1	$2.47M	Buy	+54,878	New	+$2.16M	﹤0.01%	1386

Other funds holding FLNA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Stifel Financial's FLNA Position: Q3 2026 in Review

Stifel Financial increased its Filana Therapeutics (FLNA) stake by 167% in Q3 2026, buying an estimated $118K and bringing the position to 200,000 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Stifel Financial first reported a position in FLNA in Q1 2021 and has held it in 8 quarters since. The position peaked at $5.06M in Q2 2021. 44 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.

Stifel Financial held 200,000 shares of Filana Therapeutics worth $177K as of Q3 2026.
Stifel Financial bought 125,000 Filana Therapeutics shares in Q3 2026, an estimated $118K.
Filana Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #3569 holding.
Stifel Financial first reported a position in Filana Therapeutics in Q1 2021 and has held it in 8 quarters since.
Stifel Financial's Filana Therapeutics position peaked at $5.06M in Q2 2021.
44 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.

Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.